BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 27846841)

  • 1. Integrative transcriptome network analysis of iPSC-derived neurons from schizophrenia and schizoaffective disorder patients with 22q11.2 deletion.
    Lin M; Pedrosa E; Hrabovsky A; Chen J; Puliafito BR; Gilbert SR; Zheng D; Lachman HM
    BMC Syst Biol; 2016 Nov; 10(1):105. PubMed ID: 27846841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA Profiling of Neurons Generated Using Induced Pluripotent Stem Cells Derived from Patients with Schizophrenia and Schizoaffective Disorder, and 22q11.2 Del.
    Zhao D; Lin M; Chen J; Pedrosa E; Hrabovsky A; Fourcade HM; Zheng D; Lachman HM
    PLoS One; 2015; 10(7):e0132387. PubMed ID: 26173148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial deficits in human iPSC-derived neurons from patients with 22q11.2 deletion syndrome and schizophrenia.
    Li J; Ryan SK; Deboer E; Cook K; Fitzgerald S; Lachman HM; Wallace DC; Goldberg EM; Anderson SA
    Transl Psychiatry; 2019 Nov; 9(1):302. PubMed ID: 31740674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells.
    Pedrosa E; Sandler V; Shah A; Carroll R; Chang C; Rockowitz S; Guo X; Zheng D; Lachman HM
    J Neurogenet; 2011 Oct; 25(3):88-103. PubMed ID: 21797804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells.
    Wang P; Mokhtari R; Pedrosa E; Kirschenbaum M; Bayrak C; Zheng D; Lachman HM
    Mol Autism; 2017; 8():11. PubMed ID: 28321286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoblast transcriptome analysis in 22q11.2 deletion syndrome individuals with schizophrenia-spectrum disorder.
    Michaelovsky E; Carmel M; Gothelf D; Weizman A
    World J Biol Psychiatry; 2024 Apr; 25(4):242-254. PubMed ID: 38493364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional signatures of participant-derived neural progenitor cells and neurons implicate altered Wnt signaling in Phelan-McDermid syndrome and autism.
    Breen MS; Browne A; Hoffman GE; Stathopoulos S; Brennand K; Buxbaum JD; Drapeau E
    Mol Autism; 2020 Jun; 11(1):53. PubMed ID: 32560742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene expression in the hippocampus of the Df1/+ mice: a model for 22q11.2 deletion syndrome and schizophrenia.
    Sivagnanasundaram S; Fletcher D; Hubank M; Illingworth E; Skuse D; Scambler P
    Brain Res; 2007 Mar; 1139():48-59. PubMed ID: 17292336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal Differentiation of Induced Pluripotent Stem Cells from Schizophrenia Patients in Two-Dimensional and in Three-Dimensional Cultures Reveals Increased Expression of the Kv4.2 Subunit DPP6 That Contributes to Decreased Neuronal Activity.
    Naujock M; Speidel A; Fischer S; Kizner V; Dorner-Ciossek C; Gillardon F
    Stem Cells Dev; 2020 Dec; 29(24):1577-1587. PubMed ID: 33143549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome.
    Prasad SE; Howley S; Murphy KC
    Dev Disabil Res Rev; 2008; 14(1):26-34. PubMed ID: 18636634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk gene-set and pathways in 22q11.2 deletion-related schizophrenia: a genealogical molecular approach.
    Michaelovsky E; Carmel M; Frisch A; Salmon-Divon M; Pasmanik-Chor M; Weizman A; Gothelf D
    Transl Psychiatry; 2019 Jan; 9(1):15. PubMed ID: 30710087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of deletion breakpoints in adults with 22q11 deletion syndrome.
    Weksberg R; Stachon AC; Squire JA; Moldovan L; Bayani J; Meyn S; Chow E; Bassett AS
    Hum Genet; 2007 Feb; 120(6):837-45. PubMed ID: 17028864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of genes outside the deleted region in individuals with 22q11.2 deletion syndrome.
    Dantas AG; Santoro ML; Nunes N; de Mello CB; Pimenta LSE; Meloni VA; Soares DCQ; Belangero SN; Carvalheira G; Kim CA; Melaragno MI
    Hum Genet; 2019 Jan; 138(1):93-103. PubMed ID: 30627818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between neurodevelopmental genes, neuroanatomy, and ultra high risk symptoms of psychosis in 22q11.2 deletion syndrome.
    Thompson CA; Karelis J; Middleton FA; Gentile K; Coman IL; Radoeva PD; Mehta R; Fremont WP; Antshel KM; Faraone SV; Kates WR
    Am J Med Genet B Neuropsychiatr Genet; 2017 Apr; 174(3):295-314. PubMed ID: 28139055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional gene-expression analysis shows involvement of schizophrenia-relevant pathways in patients with 22q11 deletion syndrome.
    van Beveren NJ; Krab LC; Swagemakers S; Buitendijk GH; Boot E; van der Spek P; Elgersma Y; van Amelsvoort TA
    PLoS One; 2012; 7(3):e33473. PubMed ID: 22457764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Mitochondrial Biogenesis With Variable Penetrance of Schizophrenia.
    Li J; Tran OT; Crowley TB; Moore TM; Zackai EH; Emanuel BS; McDonald-McGinn DM; Gur RE; Wallace DC; Anderson SA
    JAMA Psychiatry; 2021 Aug; 78(8):911-921. PubMed ID: 34009292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of Neurodevelopmental Deficits of 22 q11.2 Deletion Syndrome with a Patient-iPSC-Derived Blood-Brain Barrier Model.
    Li Y; Xia Y; Zhu H; Luu E; Huang G; Sun Y; Sun K; Markx S; Leong KW; Xu B; Fu BM
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered functioning of the cingulate gyrus in two cases of chromosome 22q11 deletion syndrome.
    Reif A; Fallgatter AJ; Ehlis AC; Lesch KP
    Psychiatry Res; 2004 Dec; 132(3):273-8. PubMed ID: 15664798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome.
    Bassett AS; Lowther C; Merico D; Costain G; Chow EWC; van Amelsvoort T; McDonald-McGinn D; Gur RE; Swillen A; Van den Bree M; Murphy K; Gothelf D; Bearden CE; Eliez S; Kates W; Philip N; Sashi V; Campbell L; Vorstman J; Cubells J; Repetto GM; Simon T; Boot E; Heung T; Evers R; Vingerhoets C; van Duin E; Zackai E; Vergaelen E; Devriendt K; Vermeesch JR; Owen M; Murphy C; Michaelovosky E; Kushan L; Schneider M; Fremont W; Busa T; Hooper S; McCabe K; Duijff S; Isaev K; Pellecchia G; Wei J; Gazzellone MJ; Scherer SW; Emanuel BS; Guo T; Morrow BE; Marshall CR;
    Am J Psychiatry; 2017 Nov; 174(11):1054-1063. PubMed ID: 28750581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental changes in multivariate neuroanatomical patterns that predict risk for psychosis in 22q11.2 deletion syndrome.
    Gothelf D; Hoeft F; Ueno T; Sugiura L; Lee AD; Thompson P; Reiss AL
    J Psychiatr Res; 2011 Mar; 45(3):322-31. PubMed ID: 20817203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.